nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2C19—prostate cancer	0.156	0.611	CbGaD
Pethidine—CYP3A4—prostate cancer	0.0994	0.389	CbGaD
Pethidine—ORM1—Abiraterone—prostate cancer	0.082	0.172	CbGbCtD
Pethidine—ALB—Abiraterone—prostate cancer	0.0345	0.0723	CbGbCtD
Pethidine—CYP2C19—Nilutamide—prostate cancer	0.027	0.0566	CbGbCtD
Pethidine—CYP2C19—Bicalutamide—prostate cancer	0.027	0.0566	CbGbCtD
Pethidine—CYP2B6—Estrone—prostate cancer	0.0255	0.0533	CbGbCtD
Pethidine—ALB—Estrone—prostate cancer	0.0249	0.0523	CbGbCtD
Pethidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0248	0.0521	CbGbCtD
Pethidine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0227	0.0475	CbGbCtD
Pethidine—CYP2C19—Flutamide—prostate cancer	0.0224	0.0469	CbGbCtD
Pethidine—CYP2D6—Bicalutamide—prostate cancer	0.0205	0.043	CbGbCtD
Pethidine—CYP2D6—Abiraterone—prostate cancer	0.017	0.0356	CbGbCtD
Pethidine—ALB—Estradiol—prostate cancer	0.0143	0.03	CbGbCtD
Pethidine—CYP3A4—Bicalutamide—prostate cancer	0.0131	0.0274	CbGbCtD
Pethidine—ALB—Prednisone—prostate cancer	0.0123	0.0258	CbGbCtD
Pethidine—CYP3A4—Estramustine—prostate cancer	0.0121	0.0254	CbGbCtD
Pethidine—CYP3A4—Abiraterone—prostate cancer	0.0108	0.0227	CbGbCtD
Pethidine—CYP3A4—Flutamide—prostate cancer	0.0108	0.0227	CbGbCtD
Pethidine—CYP2C19—Estradiol—prostate cancer	0.00929	0.0195	CbGbCtD
Pethidine—CYP3A4—Cabazitaxel—prostate cancer	0.008	0.0168	CbGbCtD
Pethidine—CYP2C19—Prednisone—prostate cancer	0.00799	0.0167	CbGbCtD
Pethidine—CYP3A4—Estrone—prostate cancer	0.00782	0.0164	CbGbCtD
Pethidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00697	0.0146	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—prostate cancer	0.00651	0.0136	CbGbCtD
Pethidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00511	0.0107	CbGbCtD
Pethidine—CYP3A4—Mitoxantrone—prostate cancer	0.00465	0.00974	CbGbCtD
Pethidine—CYP3A4—Estradiol—prostate cancer	0.00449	0.00941	CbGbCtD
Pethidine—CYP3A4—Prednisone—prostate cancer	0.00386	0.00809	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—prostate cancer	0.00314	0.00659	CbGbCtD
Pethidine—CYP3A4—Etoposide—prostate cancer	0.00293	0.00614	CbGbCtD
Pethidine—CYP3A4—Docetaxel—prostate cancer	0.00268	0.00562	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—prostate cancer	0.002	0.00419	CbGbCtD
Pethidine—GRIN2D—prostate gland—prostate cancer	0.00171	0.141	CbGeAlD
Pethidine—CYP2C19—urine—prostate cancer	0.00148	0.122	CbGeAlD
Pethidine—OPRK1—prostate gland—prostate cancer	0.00109	0.0895	CbGeAlD
Pethidine—CYP3A4—urine—prostate cancer	0.000878	0.0722	CbGeAlD
Pethidine—CYP2D6—urine—prostate cancer	0.000864	0.0711	CbGeAlD
Pethidine—GRIN2C—testis—prostate cancer	0.000811	0.0668	CbGeAlD
Pethidine—ORM1—prostate gland—prostate cancer	0.000755	0.0621	CbGeAlD
Pethidine—GRIN2D—testis—prostate cancer	0.000754	0.0621	CbGeAlD
Pethidine—GRIN2A—testis—prostate cancer	0.00056	0.0461	CbGeAlD
Pethidine—Ketobemidone—CYP2C19—prostate cancer	0.000553	0.228	CrCbGaD
Pethidine—Etomidate—CYP19A1—prostate cancer	0.0004	0.165	CrCbGaD
Pethidine—Levomilnacipran—CYP2C19—prostate cancer	0.000389	0.161	CrCbGaD
Pethidine—ORM1—bone marrow—prostate cancer	0.000389	0.032	CbGeAlD
Pethidine—Ketobemidone—CYP3A4—prostate cancer	0.000351	0.145	CrCbGaD
Pethidine—OPRM1—testis—prostate cancer	0.000341	0.028	CbGeAlD
Pethidine—SLC6A3—testis—prostate cancer	0.000309	0.0254	CbGeAlD
Pethidine—Methsuximide—CYP2C19—prostate cancer	0.000295	0.122	CrCbGaD
Pethidine—ALB—testis—prostate cancer	0.000292	0.024	CbGeAlD
Pethidine—CYP2B6—renal system—prostate cancer	0.000284	0.0234	CbGeAlD
Pethidine—SLC6A2—testis—prostate cancer	0.000249	0.0205	CbGeAlD
Pethidine—Levomilnacipran—CYP3A4—prostate cancer	0.000248	0.102	CrCbGaD
Pethidine—ORM1—lymph node—prostate cancer	0.000241	0.0198	CbGeAlD
Pethidine—CYP3A4—renal system—prostate cancer	0.000215	0.0177	CbGeAlD
Pethidine—ALB—lymph node—prostate cancer	0.000211	0.0174	CbGeAlD
Pethidine—CYP2D6—renal system—prostate cancer	0.000211	0.0174	CbGeAlD
Pethidine—Methylphenobarbital—CYP2C19—prostate cancer	0.000184	0.0761	CrCbGaD
Pethidine—CYP2B6—testis—prostate cancer	0.000184	0.0151	CbGeAlD
Pethidine—SLC6A2—lymph node—prostate cancer	0.000181	0.0149	CbGeAlD
Pethidine—CYP2D6—testis—prostate cancer	0.000137	0.0112	CbGeAlD
Pethidine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000129	0.000982	CcSEcCtD
Pethidine—Asthenia—Conjugated Estrogens—prostate cancer	0.000128	0.000977	CcSEcCtD
Pethidine—Bradycardia—Capecitabine—prostate cancer	0.000128	0.000974	CcSEcCtD
Pethidine—Pruritus—Goserelin—prostate cancer	0.000128	0.000973	CcSEcCtD
Pethidine—Somnolence—Estradiol—prostate cancer	0.000127	0.000969	CcSEcCtD
Pethidine—Anorexia—Mitoxantrone—prostate cancer	0.000127	0.000968	CcSEcCtD
Pethidine—Pruritus—Conjugated Estrogens—prostate cancer	0.000126	0.000964	CcSEcCtD
Pethidine—Visual impairment—Docetaxel—prostate cancer	0.000125	0.000952	CcSEcCtD
Pethidine—Hypotension—Mitoxantrone—prostate cancer	0.000124	0.000949	CcSEcCtD
Pethidine—Affect lability—Epirubicin—prostate cancer	0.000124	0.000948	CcSEcCtD
Pethidine—Decreased appetite—Estradiol—prostate cancer	0.000124	0.000948	CcSEcCtD
Pethidine—Constipation—Estradiol—prostate cancer	0.000122	0.000932	CcSEcCtD
Pethidine—Vertigo—Etoposide—prostate cancer	0.000122	0.00093	CcSEcCtD
Pethidine—Visual impairment—Capecitabine—prostate cancer	0.000121	0.000922	CcSEcCtD
Pethidine—Flushing—Docetaxel—prostate cancer	0.00012	0.000917	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—prostate cancer	0.00012	0.000916	CcSEcCtD
Pethidine—Mood swings—Epirubicin—prostate cancer	0.00012	0.000913	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—prostate cancer	0.000119	0.00091	CcSEcCtD
Pethidine—Dizziness—Goserelin—prostate cancer	0.000119	0.000909	CcSEcCtD
Pethidine—Somnolence—Mitoxantrone—prostate cancer	0.000118	0.000903	CcSEcCtD
Pethidine—Dizziness—Conjugated Estrogens—prostate cancer	0.000118	0.000901	CcSEcCtD
Pethidine—Feeling abnormal—Estradiol—prostate cancer	0.000118	0.000898	CcSEcCtD
Pethidine—Convulsion—Etoposide—prostate cancer	0.000118	0.000897	CcSEcCtD
Pethidine—Hypertension—Etoposide—prostate cancer	0.000117	0.000894	CcSEcCtD
Pethidine—Flushing—Capecitabine—prostate cancer	0.000116	0.000888	CcSEcCtD
Pethidine—Decreased appetite—Mitoxantrone—prostate cancer	0.000116	0.000883	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—prostate cancer	0.000115	0.00088	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—prostate cancer	0.000115	0.000877	CcSEcCtD
Pethidine—Vomiting—Goserelin—prostate cancer	0.000115	0.000874	CcSEcCtD
Pethidine—Constipation—Mitoxantrone—prostate cancer	0.000114	0.000869	CcSEcCtD
Pethidine—Bradycardia—Prednisone—prostate cancer	0.000114	0.000868	CcSEcCtD
Pethidine—Rash—Goserelin—prostate cancer	0.000114	0.000867	CcSEcCtD
Pethidine—Dermatitis—Goserelin—prostate cancer	0.000114	0.000866	CcSEcCtD
Pethidine—Vomiting—Conjugated Estrogens—prostate cancer	0.000113	0.000866	CcSEcCtD
Pethidine—Urticaria—Estradiol—prostate cancer	0.000113	0.000866	CcSEcCtD
Pethidine—Headache—Goserelin—prostate cancer	0.000113	0.000861	CcSEcCtD
Pethidine—Erythema—Docetaxel—prostate cancer	0.000113	0.00086	CcSEcCtD
Pethidine—Rash—Conjugated Estrogens—prostate cancer	0.000113	0.000859	CcSEcCtD
Pethidine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000112	0.000858	CcSEcCtD
Pethidine—Headache—Conjugated Estrogens—prostate cancer	0.000112	0.000853	CcSEcCtD
Pethidine—Confusional state—Etoposide—prostate cancer	0.000112	0.000852	CcSEcCtD
Pethidine—Hallucination—Prednisone—prostate cancer	0.000111	0.000848	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—prostate cancer	0.000111	0.000848	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—prostate cancer	0.000111	0.000845	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—prostate cancer	0.000111	0.000845	CcSEcCtD
Pethidine—Feeling abnormal—Mitoxantrone—prostate cancer	0.00011	0.000837	CcSEcCtD
Pethidine—Erythema—Capecitabine—prostate cancer	0.000109	0.000833	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—prostate cancer	0.000108	0.000827	CcSEcCtD
Pethidine—Tachycardia—Etoposide—prostate cancer	0.000108	0.000824	CcSEcCtD
Pethidine—Nausea—Goserelin—prostate cancer	0.000107	0.000817	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—prostate cancer	0.000107	0.000817	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000107	0.000814	CcSEcCtD
Pethidine—Nausea—Conjugated Estrogens—prostate cancer	0.000106	0.000809	CcSEcCtD
Pethidine—Urticaria—Mitoxantrone—prostate cancer	0.000106	0.000807	CcSEcCtD
Pethidine—Anorexia—Etoposide—prostate cancer	0.000106	0.000805	CcSEcCtD
Pethidine—Hypersensitivity—Estradiol—prostate cancer	0.000105	0.000803	CcSEcCtD
Pethidine—Muscle spasms—Capecitabine—prostate cancer	0.000105	0.000801	CcSEcCtD
Pethidine—Flushing—Prednisone—prostate cancer	0.000104	0.000791	CcSEcCtD
Pethidine—Hypotension—Etoposide—prostate cancer	0.000103	0.000789	CcSEcCtD
Pethidine—Asthenia—Estradiol—prostate cancer	0.000103	0.000782	CcSEcCtD
Pethidine—Tremor—Capecitabine—prostate cancer	0.000102	0.00078	CcSEcCtD
Pethidine—Syncope—Docetaxel—prostate cancer	0.000101	0.000771	CcSEcCtD
Pethidine—Pruritus—Estradiol—prostate cancer	0.000101	0.000771	CcSEcCtD
Pethidine—Palpitations—Docetaxel—prostate cancer	9.96e-05	0.00076	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—prostate cancer	9.91e-05	0.000756	CcSEcCtD
Pethidine—Somnolence—Etoposide—prostate cancer	9.84e-05	0.000751	CcSEcCtD
Pethidine—Vertigo—Capecitabine—prostate cancer	9.81e-05	0.000748	CcSEcCtD
Pethidine—Hypersensitivity—Mitoxantrone—prostate cancer	9.81e-05	0.000748	CcSEcCtD
Pethidine—Syncope—Capecitabine—prostate cancer	9.79e-05	0.000747	CcSEcCtD
Pethidine—Convulsion—Docetaxel—prostate cancer	9.77e-05	0.000745	CcSEcCtD
Pethidine—Hypertension—Docetaxel—prostate cancer	9.73e-05	0.000743	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—prostate cancer	9.73e-05	0.000742	CcSEcCtD
Pethidine—Erythema—Prednisone—prostate cancer	9.72e-05	0.000742	CcSEcCtD
Pethidine—Palpitations—Capecitabine—prostate cancer	9.65e-05	0.000736	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—prostate cancer	9.63e-05	0.000734	CcSEcCtD
Pethidine—Loss of consciousness—Capecitabine—prostate cancer	9.59e-05	0.000732	CcSEcCtD
Pethidine—Asthenia—Mitoxantrone—prostate cancer	9.55e-05	0.000729	CcSEcCtD
Pethidine—Constipation—Etoposide—prostate cancer	9.47e-05	0.000722	CcSEcCtD
Pethidine—Dizziness—Estradiol—prostate cancer	9.45e-05	0.000721	CcSEcCtD
Pethidine—Hypertension—Capecitabine—prostate cancer	9.42e-05	0.000719	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—prostate cancer	9.39e-05	0.000716	CcSEcCtD
Pethidine—Sweating—Epirubicin—prostate cancer	9.33e-05	0.000712	CcSEcCtD
Pethidine—Confusional state—Docetaxel—prostate cancer	9.28e-05	0.000708	CcSEcCtD
Pethidine—Anxiety—Capecitabine—prostate cancer	9.26e-05	0.000707	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—prostate cancer	9.2e-05	0.000702	CcSEcCtD
Pethidine—Oedema—Docetaxel—prostate cancer	9.2e-05	0.000702	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—prostate cancer	9.12e-05	0.000696	CcSEcCtD
Pethidine—Dry mouth—Capecitabine—prostate cancer	9.09e-05	0.000693	CcSEcCtD
Pethidine—Vomiting—Estradiol—prostate cancer	9.08e-05	0.000693	CcSEcCtD
Pethidine—Shock—Docetaxel—prostate cancer	9.05e-05	0.000691	CcSEcCtD
Pethidine—Rash—Estradiol—prostate cancer	9.01e-05	0.000687	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—prostate cancer	9e-05	0.000687	CcSEcCtD
Pethidine—Dermatitis—Estradiol—prostate cancer	9e-05	0.000687	CcSEcCtD
Pethidine—Confusional state—Capecitabine—prostate cancer	8.98e-05	0.000685	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—prostate cancer	8.98e-05	0.000685	CcSEcCtD
Pethidine—Headache—Estradiol—prostate cancer	8.95e-05	0.000683	CcSEcCtD
Pethidine—Agitation—Prednisone—prostate cancer	8.94e-05	0.000682	CcSEcCtD
Pethidine—Oedema—Capecitabine—prostate cancer	8.91e-05	0.00068	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—prostate cancer	8.89e-05	0.000679	CcSEcCtD
Pethidine—Urticaria—Etoposide—prostate cancer	8.8e-05	0.000671	CcSEcCtD
Pethidine—Anorexia—Docetaxel—prostate cancer	8.77e-05	0.000669	CcSEcCtD
Pethidine—Shock—Capecitabine—prostate cancer	8.77e-05	0.000669	CcSEcCtD
Pethidine—Vertigo—Prednisone—prostate cancer	8.74e-05	0.000667	CcSEcCtD
Pethidine—Syncope—Prednisone—prostate cancer	8.72e-05	0.000665	CcSEcCtD
Pethidine—Tachycardia—Capecitabine—prostate cancer	8.7e-05	0.000663	CcSEcCtD
Pethidine—Sweating—Doxorubicin—prostate cancer	8.63e-05	0.000659	CcSEcCtD
Pethidine—Hyperhidrosis—Capecitabine—prostate cancer	8.61e-05	0.000657	CcSEcCtD
Pethidine—Hypotension—Docetaxel—prostate cancer	8.6e-05	0.000656	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—prostate cancer	8.55e-05	0.000652	CcSEcCtD
Pethidine—Anorexia—Capecitabine—prostate cancer	8.49e-05	0.000648	CcSEcCtD
Pethidine—Nausea—Estradiol—prostate cancer	8.49e-05	0.000647	CcSEcCtD
Pethidine—Vomiting—Mitoxantrone—prostate cancer	8.46e-05	0.000646	CcSEcCtD
Pethidine—Convulsion—Prednisone—prostate cancer	8.42e-05	0.000643	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—prostate cancer	8.42e-05	0.000642	CcSEcCtD
Pethidine—Hypertension—Prednisone—prostate cancer	8.4e-05	0.000641	CcSEcCtD
Pethidine—Rash—Mitoxantrone—prostate cancer	8.39e-05	0.00064	CcSEcCtD
Pethidine—Dermatitis—Mitoxantrone—prostate cancer	8.39e-05	0.00064	CcSEcCtD
Pethidine—Headache—Mitoxantrone—prostate cancer	8.34e-05	0.000636	CcSEcCtD
Pethidine—Hypotension—Capecitabine—prostate cancer	8.32e-05	0.000635	CcSEcCtD
Pethidine—Insomnia—Docetaxel—prostate cancer	8.32e-05	0.000635	CcSEcCtD
Pethidine—Anxiety—Prednisone—prostate cancer	8.25e-05	0.000629	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—prostate cancer	8.23e-05	0.000628	CcSEcCtD
Pethidine—Somnolence—Docetaxel—prostate cancer	8.18e-05	0.000624	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—prostate cancer	8.16e-05	0.000622	CcSEcCtD
Pethidine—Flushing—Epirubicin—prostate cancer	8.11e-05	0.000619	CcSEcCtD
Pethidine—Insomnia—Capecitabine—prostate cancer	8.06e-05	0.000615	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—prostate cancer	8e-05	0.00061	CcSEcCtD
Pethidine—Asthenia—Etoposide—prostate cancer	7.94e-05	0.000606	CcSEcCtD
Pethidine—Oedema—Prednisone—prostate cancer	7.94e-05	0.000605	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—prostate cancer	7.94e-05	0.000605	CcSEcCtD
Pethidine—Nausea—Mitoxantrone—prostate cancer	7.91e-05	0.000603	CcSEcCtD
Pethidine—Constipation—Docetaxel—prostate cancer	7.87e-05	0.0006	CcSEcCtD
Pethidine—Pruritus—Etoposide—prostate cancer	7.83e-05	0.000598	CcSEcCtD
Pethidine—Shock—Prednisone—prostate cancer	7.81e-05	0.000596	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—prostate cancer	7.79e-05	0.000594	CcSEcCtD
Pethidine—Tachycardia—Prednisone—prostate cancer	7.75e-05	0.000591	CcSEcCtD
Pethidine—Decreased appetite—Capecitabine—prostate cancer	7.74e-05	0.000591	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisone—prostate cancer	7.67e-05	0.000585	CcSEcCtD
Pethidine—Constipation—Capecitabine—prostate cancer	7.62e-05	0.000581	CcSEcCtD
Pethidine—Erythema—Epirubicin—prostate cancer	7.6e-05	0.00058	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—prostate cancer	7.58e-05	0.000579	CcSEcCtD
Pethidine—Anorexia—Prednisone—prostate cancer	7.56e-05	0.000577	CcSEcCtD
Pethidine—Flushing—Doxorubicin—prostate cancer	7.5e-05	0.000572	CcSEcCtD
Pethidine—Feeling abnormal—Capecitabine—prostate cancer	7.34e-05	0.00056	CcSEcCtD
Pethidine—Dizziness—Etoposide—prostate cancer	7.32e-05	0.000559	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—prostate cancer	7.31e-05	0.000558	CcSEcCtD
Pethidine—Insomnia—Prednisone—prostate cancer	7.18e-05	0.000548	CcSEcCtD
Pethidine—Urticaria—Capecitabine—prostate cancer	7.08e-05	0.00054	CcSEcCtD
Pethidine—Vomiting—Etoposide—prostate cancer	7.04e-05	0.000537	CcSEcCtD
Pethidine—Erythema—Doxorubicin—prostate cancer	7.04e-05	0.000537	CcSEcCtD
Pethidine—Agitation—Epirubicin—prostate cancer	6.99e-05	0.000533	CcSEcCtD
Pethidine—Rash—Etoposide—prostate cancer	6.98e-05	0.000533	CcSEcCtD
Pethidine—Dermatitis—Etoposide—prostate cancer	6.97e-05	0.000532	CcSEcCtD
Pethidine—Headache—Etoposide—prostate cancer	6.94e-05	0.000529	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—prostate cancer	6.9e-05	0.000526	CcSEcCtD
Pethidine—Vertigo—Epirubicin—prostate cancer	6.83e-05	0.000521	CcSEcCtD
Pethidine—Syncope—Epirubicin—prostate cancer	6.82e-05	0.00052	CcSEcCtD
Pethidine—Constipation—Prednisone—prostate cancer	6.79e-05	0.000518	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—prostate cancer	6.78e-05	0.000517	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—prostate cancer	6.77e-05	0.000516	CcSEcCtD
Pethidine—Palpitations—Epirubicin—prostate cancer	6.72e-05	0.000513	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—prostate cancer	6.68e-05	0.00051	CcSEcCtD
Pethidine—Asthenia—Docetaxel—prostate cancer	6.6e-05	0.000504	CcSEcCtD
Pethidine—Convulsion—Epirubicin—prostate cancer	6.59e-05	0.000503	CcSEcCtD
Pethidine—Nausea—Etoposide—prostate cancer	6.58e-05	0.000502	CcSEcCtD
Pethidine—Hypertension—Epirubicin—prostate cancer	6.57e-05	0.000501	CcSEcCtD
Pethidine—Hypersensitivity—Capecitabine—prostate cancer	6.56e-05	0.000501	CcSEcCtD
Pethidine—Feeling abnormal—Prednisone—prostate cancer	6.54e-05	0.000499	CcSEcCtD
Pethidine—Pruritus—Docetaxel—prostate cancer	6.51e-05	0.000497	CcSEcCtD
Pethidine—Agitation—Doxorubicin—prostate cancer	6.47e-05	0.000493	CcSEcCtD
Pethidine—Anxiety—Epirubicin—prostate cancer	6.45e-05	0.000492	CcSEcCtD
Pethidine—Asthenia—Capecitabine—prostate cancer	6.39e-05	0.000488	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—prostate cancer	6.33e-05	0.000483	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—prostate cancer	6.32e-05	0.000482	CcSEcCtD
Pethidine—Syncope—Doxorubicin—prostate cancer	6.31e-05	0.000481	CcSEcCtD
Pethidine—Urticaria—Prednisone—prostate cancer	6.3e-05	0.000481	CcSEcCtD
Pethidine—Pruritus—Capecitabine—prostate cancer	6.3e-05	0.000481	CcSEcCtD
Pethidine—Confusional state—Epirubicin—prostate cancer	6.26e-05	0.000477	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—prostate cancer	6.22e-05	0.000474	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—prostate cancer	6.21e-05	0.000474	CcSEcCtD
Pethidine—Oedema—Epirubicin—prostate cancer	6.21e-05	0.000474	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—prostate cancer	6.18e-05	0.000472	CcSEcCtD
Pethidine—Shock—Epirubicin—prostate cancer	6.11e-05	0.000466	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—prostate cancer	6.1e-05	0.000465	CcSEcCtD
Pethidine—Dizziness—Docetaxel—prostate cancer	6.09e-05	0.000464	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—prostate cancer	6.08e-05	0.000464	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—prostate cancer	6.06e-05	0.000462	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—prostate cancer	6e-05	0.000458	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—prostate cancer	5.97e-05	0.000455	CcSEcCtD
Pethidine—Anorexia—Epirubicin—prostate cancer	5.92e-05	0.000451	CcSEcCtD
Pethidine—Dizziness—Capecitabine—prostate cancer	5.89e-05	0.000449	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—prostate cancer	5.86e-05	0.000447	CcSEcCtD
Pethidine—Vomiting—Docetaxel—prostate cancer	5.85e-05	0.000446	CcSEcCtD
Pethidine—Hypersensitivity—Prednisone—prostate cancer	5.85e-05	0.000446	CcSEcCtD
Pethidine—Rash—Docetaxel—prostate cancer	5.8e-05	0.000443	CcSEcCtD
Pethidine—Hypotension—Epirubicin—prostate cancer	5.8e-05	0.000442	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—prostate cancer	5.8e-05	0.000442	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—prostate cancer	5.79e-05	0.000442	CcSEcCtD
Pethidine—Headache—Docetaxel—prostate cancer	5.76e-05	0.00044	CcSEcCtD
Pethidine—Oedema—Doxorubicin—prostate cancer	5.74e-05	0.000438	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—prostate cancer	5.74e-05	0.000438	CcSEcCtD
Pethidine—Asthenia—Prednisone—prostate cancer	5.69e-05	0.000434	CcSEcCtD
Pethidine—Vomiting—Capecitabine—prostate cancer	5.66e-05	0.000432	CcSEcCtD
Pethidine—Shock—Doxorubicin—prostate cancer	5.65e-05	0.000431	CcSEcCtD
Pethidine—Rash—Capecitabine—prostate cancer	5.62e-05	0.000429	CcSEcCtD
Pethidine—Pruritus—Prednisone—prostate cancer	5.61e-05	0.000428	CcSEcCtD
Pethidine—Insomnia—Epirubicin—prostate cancer	5.61e-05	0.000428	CcSEcCtD
Pethidine—Dermatitis—Capecitabine—prostate cancer	5.61e-05	0.000428	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—prostate cancer	5.6e-05	0.000428	CcSEcCtD
Pethidine—Headache—Capecitabine—prostate cancer	5.58e-05	0.000426	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—prostate cancer	5.55e-05	0.000424	CcSEcCtD
Pethidine—Somnolence—Epirubicin—prostate cancer	5.52e-05	0.000421	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—prostate cancer	5.47e-05	0.000418	CcSEcCtD
Pethidine—Nausea—Docetaxel—prostate cancer	5.47e-05	0.000417	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—prostate cancer	5.4e-05	0.000412	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—prostate cancer	5.37e-05	0.000409	CcSEcCtD
Pethidine—Constipation—Epirubicin—prostate cancer	5.31e-05	0.000405	CcSEcCtD
Pethidine—Nausea—Capecitabine—prostate cancer	5.29e-05	0.000404	CcSEcCtD
Pethidine—Dizziness—Prednisone—prostate cancer	5.25e-05	0.0004	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—prostate cancer	5.19e-05	0.000396	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—prostate cancer	5.11e-05	0.00039	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—prostate cancer	5.11e-05	0.00039	CcSEcCtD
Pethidine—Vomiting—Prednisone—prostate cancer	5.05e-05	0.000385	CcSEcCtD
Pethidine—Rash—Prednisone—prostate cancer	5e-05	0.000382	CcSEcCtD
Pethidine—Dermatitis—Prednisone—prostate cancer	5e-05	0.000381	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—prostate cancer	4.99e-05	0.000381	CcSEcCtD
Pethidine—Headache—Prednisone—prostate cancer	4.97e-05	0.000379	CcSEcCtD
Pethidine—Urticaria—Epirubicin—prostate cancer	4.93e-05	0.000376	CcSEcCtD
Pethidine—Constipation—Doxorubicin—prostate cancer	4.91e-05	0.000375	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—prostate cancer	4.73e-05	0.000361	CcSEcCtD
Pethidine—Nausea—Prednisone—prostate cancer	4.71e-05	0.00036	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—prostate cancer	4.57e-05	0.000349	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—prostate cancer	4.56e-05	0.000348	CcSEcCtD
Pethidine—Asthenia—Epirubicin—prostate cancer	4.45e-05	0.00034	CcSEcCtD
Pethidine—Pruritus—Epirubicin—prostate cancer	4.39e-05	0.000335	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—prostate cancer	4.23e-05	0.000323	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—prostate cancer	4.12e-05	0.000314	CcSEcCtD
Pethidine—Dizziness—Epirubicin—prostate cancer	4.1e-05	0.000313	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—prostate cancer	4.06e-05	0.00031	CcSEcCtD
Pethidine—Vomiting—Epirubicin—prostate cancer	3.95e-05	0.000301	CcSEcCtD
Pethidine—Rash—Epirubicin—prostate cancer	3.91e-05	0.000299	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—prostate cancer	3.91e-05	0.000298	CcSEcCtD
Pethidine—Headache—Epirubicin—prostate cancer	3.89e-05	0.000297	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—prostate cancer	3.8e-05	0.00029	CcSEcCtD
Pethidine—Nausea—Epirubicin—prostate cancer	3.69e-05	0.000281	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—prostate cancer	3.65e-05	0.000279	CcSEcCtD
Pethidine—Rash—Doxorubicin—prostate cancer	3.62e-05	0.000276	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—prostate cancer	3.62e-05	0.000276	CcSEcCtD
Pethidine—Headache—Doxorubicin—prostate cancer	3.6e-05	0.000274	CcSEcCtD
Pethidine—Nausea—Doxorubicin—prostate cancer	3.41e-05	0.00026	CcSEcCtD
Pethidine—CYP2D6—Metabolism—NCOA2—prostate cancer	3.16e-06	2.6e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—LPL—prostate cancer	3.15e-06	2.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	3.14e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—prostate cancer	3.14e-06	2.58e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—prostate cancer	3.13e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGF2—prostate cancer	3.12e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TH—prostate cancer	3.12e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.1e-06	2.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGF—prostate cancer	3.1e-06	2.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IRS1—prostate cancer	3.1e-06	2.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA2—prostate cancer	3.1e-06	2.55e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.09e-06	2.54e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOS3—prostate cancer	3.08e-06	2.54e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.07e-06	2.53e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—RXRA—prostate cancer	3.07e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG5—prostate cancer	3.06e-06	2.52e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.06e-06	2.52e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.04e-06	2.51e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—prostate cancer	3.04e-06	2.5e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.04e-06	2.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ERCC2—prostate cancer	3.02e-06	2.49e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.02e-06	2.48e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GSK3B—prostate cancer	3.01e-06	2.48e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JAK2—prostate cancer	2.99e-06	2.47e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.99e-06	2.46e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.98e-06	2.46e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—INS—prostate cancer	2.97e-06	2.44e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—prostate cancer	2.96e-06	2.44e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—COMT—prostate cancer	2.96e-06	2.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.96e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAT2—prostate cancer	2.96e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.96e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.95e-06	2.43e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—prostate cancer	2.94e-06	2.42e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GGT1—prostate cancer	2.94e-06	2.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	2.93e-06	2.42e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—prostate cancer	2.92e-06	2.41e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—prostate cancer	2.91e-06	2.4e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREBBP—prostate cancer	2.91e-06	2.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.9e-06	2.39e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ITPR1—prostate cancer	2.9e-06	2.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—prostate cancer	2.88e-06	2.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—prostate cancer	2.87e-06	2.36e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TH—prostate cancer	2.87e-06	2.36e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—prostate cancer	2.86e-06	2.35e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.85e-06	2.35e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.85e-06	2.34e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	2.84e-06	2.34e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.84e-06	2.34e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—prostate cancer	2.84e-06	2.34e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.83e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LRP2—prostate cancer	2.83e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.83e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.79e-06	2.3e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARA—prostate cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—P4HB—prostate cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	2.77e-06	2.29e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	2.76e-06	2.27e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—RXRA—prostate cancer	2.75e-06	2.27e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—prostate cancer	2.74e-06	2.25e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—prostate cancer	2.73e-06	2.25e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	2.73e-06	2.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	2.73e-06	2.25e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—prostate cancer	2.72e-06	2.24e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GGT1—prostate cancer	2.7e-06	2.23e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—prostate cancer	2.7e-06	2.23e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.7e-06	2.23e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—prostate cancer	2.7e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.68e-06	2.21e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	2.67e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.66e-06	2.19e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—LPL—prostate cancer	2.65e-06	2.19e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—COMT—prostate cancer	2.65e-06	2.19e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.64e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF2—prostate cancer	2.64e-06	2.17e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	2.64e-06	2.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.63e-06	2.17e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.63e-06	2.16e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAV1—prostate cancer	2.62e-06	2.16e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—prostate cancer	2.61e-06	2.15e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—prostate cancer	2.61e-06	2.15e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOS3—prostate cancer	2.6e-06	2.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.6e-06	2.14e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—prostate cancer	2.6e-06	2.14e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MED12—prostate cancer	2.59e-06	2.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNG5—prostate cancer	2.57e-06	2.12e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—prostate cancer	2.56e-06	2.11e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.56e-06	2.1e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—prostate cancer	2.55e-06	2.1e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ERCC2—prostate cancer	2.54e-06	2.09e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—RXRA—prostate cancer	2.53e-06	2.09e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JAK2—prostate cancer	2.53e-06	2.08e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	2.52e-06	2.08e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—prostate cancer	2.52e-06	2.07e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.48e-06	2.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—prostate cancer	2.47e-06	2.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—prostate cancer	2.47e-06	2.03e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	2.46e-06	2.03e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—prostate cancer	2.46e-06	2.02e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—prostate cancer	2.46e-06	2.02e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—COMT—prostate cancer	2.44e-06	2.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—prostate cancer	2.43e-06	2.01e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.43e-06	2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.43e-06	2e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	2.4e-06	1.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—prostate cancer	2.4e-06	1.97e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.39e-06	1.97e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—prostate cancer	2.39e-06	1.97e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.39e-06	1.96e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—LPL—prostate cancer	2.38e-06	1.96e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.36e-06	1.95e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.35e-06	1.93e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARA—prostate cancer	2.34e-06	1.93e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—prostate cancer	2.34e-06	1.93e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—prostate cancer	2.31e-06	1.91e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—prostate cancer	2.31e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.3e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.29e-06	1.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ACHE—prostate cancer	2.29e-06	1.89e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.28e-06	1.88e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—prostate cancer	2.28e-06	1.88e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.27e-06	1.87e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—prostate cancer	2.26e-06	1.86e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—INS—prostate cancer	2.26e-06	1.86e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	2.25e-06	1.86e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—prostate cancer	2.24e-06	1.84e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.23e-06	1.84e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	2.23e-06	1.84e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—prostate cancer	2.22e-06	1.83e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CREBBP—prostate cancer	2.21e-06	1.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—prostate cancer	2.21e-06	1.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—prostate cancer	2.21e-06	1.82e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAV1—prostate cancer	2.2e-06	1.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—prostate cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—prostate cancer	2.2e-06	1.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.19e-06	1.81e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—LPL—prostate cancer	2.19e-06	1.8e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.17e-06	1.79e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—prostate cancer	2.15e-06	1.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.15e-06	1.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	2.13e-06	1.75e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.12e-06	1.74e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.11e-06	1.73e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARA—prostate cancer	2.1e-06	1.73e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.1e-06	1.73e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.1e-06	1.73e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—prostate cancer	2.09e-06	1.72e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	2.08e-06	1.71e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—prostate cancer	2.08e-06	1.71e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.07e-06	1.7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—prostate cancer	2.04e-06	1.68e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—prostate cancer	2.04e-06	1.68e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—prostate cancer	2.03e-06	1.67e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—prostate cancer	2.01e-06	1.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—prostate cancer	2e-06	1.64e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—prostate cancer	1.98e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NOS3—prostate cancer	1.98e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAV1—prostate cancer	1.98e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.97e-06	1.63e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.97e-06	1.62e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARA—prostate cancer	1.94e-06	1.59e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.93e-06	1.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—prostate cancer	1.93e-06	1.59e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—prostate cancer	1.9e-06	1.57e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—INS—prostate cancer	1.9e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.89e-06	1.56e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—prostate cancer	1.89e-06	1.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—prostate cancer	1.89e-06	1.55e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TH—prostate cancer	1.88e-06	1.55e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—prostate cancer	1.88e-06	1.54e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CREBBP—prostate cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—prostate cancer	1.86e-06	1.53e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.83e-06	1.51e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.83e-06	1.5e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAV1—prostate cancer	1.82e-06	1.5e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.81e-06	1.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.8e-06	1.48e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GGT1—prostate cancer	1.77e-06	1.46e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—prostate cancer	1.76e-06	1.45e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.74e-06	1.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	1.73e-06	1.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—prostate cancer	1.73e-06	1.42e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—prostate cancer	1.72e-06	1.42e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.72e-06	1.41e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—INS—prostate cancer	1.71e-06	1.41e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—prostate cancer	1.69e-06	1.39e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—prostate cancer	1.68e-06	1.38e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.67e-06	1.38e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NOS3—prostate cancer	1.67e-06	1.37e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.66e-06	1.37e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RXRA—prostate cancer	1.66e-06	1.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COMT—prostate cancer	1.6e-06	1.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—prostate cancer	1.59e-06	1.31e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.59e-06	1.31e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—prostate cancer	1.58e-06	1.3e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—INS—prostate cancer	1.57e-06	1.29e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.56e-06	1.29e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—prostate cancer	1.54e-06	1.27e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.54e-06	1.27e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—prostate cancer	1.53e-06	1.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—prostate cancer	1.52e-06	1.26e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—prostate cancer	1.51e-06	1.24e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NOS3—prostate cancer	1.5e-06	1.23e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—prostate cancer	1.48e-06	1.22e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.46e-06	1.2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—LPL—prostate cancer	1.43e-06	1.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—prostate cancer	1.42e-06	1.17e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.42e-06	1.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NOS3—prostate cancer	1.38e-06	1.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.37e-06	1.13e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.37e-06	1.13e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—prostate cancer	1.33e-06	1.09e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—prostate cancer	1.3e-06	1.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARA—prostate cancer	1.27e-06	1.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.26e-06	1.04e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.2e-06	9.85e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—prostate cancer	1.19e-06	9.83e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAV1—prostate cancer	1.19e-06	9.8e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—prostate cancer	1.14e-06	9.37e-06	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.11e-06	9.18e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—prostate cancer	1.1e-06	9.04e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.08e-06	8.93e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—prostate cancer	1.05e-06	8.62e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—INS—prostate cancer	1.03e-06	8.45e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CREBBP—prostate cancer	1e-06	8.28e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.53e-07	7.85e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—prostate cancer	9.38e-07	7.72e-06	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—prostate cancer	9.1e-07	7.5e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NOS3—prostate cancer	9e-07	7.41e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.42e-07	6.93e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.3e-07	6.84e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—prostate cancer	8.23e-07	6.78e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.74e-07	6.38e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—prostate cancer	7.66e-07	6.31e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—prostate cancer	7.18e-07	5.91e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—prostate cancer	6.88e-07	5.66e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—prostate cancer	6.84e-07	5.64e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—prostate cancer	6.33e-07	5.21e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.06e-07	4.17e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—prostate cancer	4.14e-07	3.41e-06	CbGpPWpGaD
